0

17-(Allylamino)-17-demethoxygeldanamycin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP75747147
CAS75747-14-7
Structure
MDL NumberMFCD04973892
Molecular Weight585.69
InChI KeyAYUNIORJHRXIBJ-TXHRRWQRSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: soluble; methanol: soluble
Assay≥98% (HPLC)
Formsolid
Size500UG
Storage Conditions−20°C
1

17-allylamino-17-demethoxygeldanamycin Impeded Chemotherapy Through Antioxidant Activation via Reducing Reactive Oxygen Species-Induced Cell Death

Yueqi Li, Yiyang Chen, Cen Qiu, Xiaoying Ma, Kecheng Lei, Guoxiang Cai, Xin Liang, Jianwen Liu

J Cell Biochem. 2018 Oct 30.

PMID: 30378153

1

17-Allylamino-17-demethoxygeldanamycin-induced Changes in [ 18 F]Fluorothymidine Uptake

Hang Jung Lee, DO Hyung Kim, Seung Jin Lee

Anticancer Res. 2017 Jun;37(6):2993-2999.

PMID: 28551637

1

A Phase II Trial of 17-(Allylamino)-17-demethoxygeldanamycin in Patients With Papillary and Clear Cell Renal Cell Carcinoma

Ellen A Ronnen, G Varuni Kondagunta, Nicole Ishill, Suzanne M Sweeney, John K Deluca, Lawrence Schwartz, Jennifer Bacik, Robert J Motzer

Invest New Drugs. 2006 Nov;24(6):543-6.

PMID: 16832603

1

The Geldanamycin Analogue 17-allylamino-17-demethoxygeldanamycin Inhibits the Growth of GL261 Glioma Cells in Vitro and in Vivo

Elizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, Mine Esencay, Ingeborg Fischer, David Hong, Yongzhao Shao, David Zagzag

Anticancer Drugs. 2007 Sep;18(8):875-82.

PMID: 17667592

1

Utility of 17-(allylamino)-17-demethoxygeldanamycin Treatment for Skeletal Muscle Injury

Cory W Baumann, Russell G Rogers, Jeffrey S Otis

Cell Stress Chaperones. 2016 Nov;21(6):1111-1117.

PMID: 27401091

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode